Published in Drug Week, June 16th, 2006
According to a recent report, researchers in Sweden conducted a study "to evaluate the diagnostic accuracy of esophageal and cardia adenocarcinoma in the Swedish Cancer Register. Based on cancer registers, a rising incidence of esophageal and cardia adenocarcinoma has been reported in several, but possible influence of differences in tumor classification has not been evaluated. In a nationwide study in 1995 through 1997, all Swedish patients, born in Sweden and younger than 80 years with esophageal or cardia...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.